Commentary: The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision

International Journal of Epidemiology

Volumn 36, Issue 4, 2007, Pages 713-717

  Pearce, Neil ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASBESTOS; DIETHYLSTILBESTROL; ORAL CONTRACEPTIVE AGENT;

CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DRUG USE; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; RESEARCH ETHICS; REYE SYNDROME; RISK FACTOR; THROMBOEMBOLISM; VAGINA CANCER;

COMMERCE; EPIDEMIOLOGY; FINANCIAL SUPPORT; FORECASTING; HUMANS; RESEARCH DESIGN;

EID: 34548593474     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym152     Document Type: Note

References (52)

1. Rothman KJ. The rise and fall of epidemiology, 1950-2000 AD. New England J Med 1981;304:600-2. Reprinted Int J Epidemiol.
2. Pearce N, McKinlay JB. Back to the future in epidemiology and public health. J Clin Epidemiol 1999; 51:645-46; discussion 647-49.
3. Ebrahim S. Obesity, fat, and public health. Int J Epidemiol 2006;35:1-2.
4. Ezzatt M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
5. Pearce N, Matos E, Vainio H et al. Occupational cancer in developing countries. Lyon: IARC, 1994.
6. Pearce N. The globalization of epidemiology: Introductory remarks. International J Epidemiol 2004;33:1127-31.
7. McMichael AJ. The health of persons, populations, and planets: epidemiology comes full circle. Epidemiology, 1995;6:633-136.
8. Men T, Brennan P, Boffetta P, Zaridze D. Russian mortality trends for 1991-2001: Analysis by cause and region. Br Med J 2005;327 964-66.
9. Davey Smith G, Ebrahim S. Epidemiology - is it time to call it a day? Int J Epidemiol 2001;301:1-11.
10. Rothman K. Modern Epidemiology. Boston, MA: Little: Brown, 1986.
11. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am J Public Health 1996;86:678-43.
12. Pearce N. Epidemiology as a population science. Int J Epidemiol 1999;28:S1015-18.
13. Pearce N. The ecological fallacy strikes back. J Epidemiol Community Health.2000;54:326-27.
14. Davey Smith G. Reflections on the limitation to epidemiology. J Clin Epidemiol 2001;54:325-31.
15. Douwes J, Pearce N. Asthma and the westernization 'package'. Int J Epidemiol 2002;31:1098-102.
16. Rothman KJ, Adami HO, Trichopoulos D. Should the mission of epidemiology include the eradication of poverty? Lancet 1998;352:810-13.
17. Greenland S. Science versus advocacy: The challenge of Dr Feinstein. Epidemiology 1991;2: 64-72.
18. Savitz DA, Greenland S, Stolley PD, Kelsey JL. Scientific standards of criticism: A reaction to "Scientific standards in epidemiologic studies of the menace of daily life." by A.R. Feinstein. Epidemiology 1990;1:78-83.
19. Pearce N. Adverse reactions, social responses: A tale of two asthma mortality epidemics. In: Davis P (ed.). Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs. New York: Oxford University Press, 1996. pp. 57-75.
20. Brodeur P. Outrageous Misconduct: The Asbestos Industry on Trial. New York: Pantheon, 1985.
21. Levenstein C. The Open Secret: The Recognition of Brown Lung. Ithaca: Cornell University press, 1991.
22. Egilman D. Corporate corruption of science - the case of chromium(VI). Int J Occupational Environmental Health 2006;12:169-76.
23. Friedman LS, Richter ED. Conflicts of interest and scientific integrity. Int J Occupational Environmental Health 2005;11:205-6.
24. Hardell L, Walker MJ, Walhjalt B et al. Secret ties to industry and conflicting interests in cancer research. Am J Ind Med 2007; 50:227-33.
25. Michaels D. Scientific evidence and public policy. Am J Public Health 2005;95:S5-7.
26. Michaels D, Bingham E, Boden L et al. Advice without dissent. Science 2002;298:703.
27. Michaels D, Monforton C. Manufacturing uncertainty: Contested science and the protection of the public's health and environment. Am J Public Health 2005;95:S39-48.
28. Michaels D, Monforton C, Lurie P. Selected science: An industry campaign to undermine an OSHA hexavalent chromium standard. Environmental Health 2006;5:10.1186/1476-069X-5-5.
29. Monforton C. Weight of the evidence or wait for the evidence? Protecting underground miners from Diesel particulate matter. Am J Public Health 2006;96:271-76.
30. Clapp R, Hoppin P, Kriebel D. Erosion of the integrity of public health science in the USA. Occupational Environmental Med 2006;63 367-68.
31. Stolley PD. A public health perspective from academia. in: Strom BL (ed.). Pharmacoepidemiology. New York: Churchill Livingstone, 1989.
32. Pearce N, Crawford-Brown D. Critical discussion in epidemiology: problems with the Popperian approach. J Clin Epidemiol 1989;42 177-84.
33. Rothman KJ. Conflict of interest: The new McCarthyism in science. J Am Med Association 1993;269:2782-84.
34. Rothman KJ, Evans S. Extra scrutiny for industry funded trials - JAMA's demand for an additional hurdle is unfair - and absurd. Br Med J 2005;331:1350-51.
35. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. J Am Med Association 1998; 279:1566-70.
36. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. New Engl J Med 1998; 338:101-6.
37. McMichael AJ. Prisoners of the proximate: Loosening the constraints on epidemiology in an age of change. Am J Epidemiol 1999;149 887-97.
38. McMichael AJ, Beaglehole R. The changing global context of public health. Lancet 2000;356:495-99.
39. McMichael AJ, Haines A. Global climate change: The potential effects on health. [comment]. Br Med J 1997;315:805-9.
40. McMichael AJ, Powles JW. Human numbers, environment, sustainability, and health. [comment]. Br Med J 1999;319:977-80.
41. McMichael AJ, Smith KR, Corvalan CF. The Sustainability transition: A new challenge. Bull World Health Organization 2000;78:1067.
42. Susser M. Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health 1998;52 608-11.
43. Susser M, Susser E. Choosing a future for epidemiology: I. Bras and paradigms. Am J Public Health 1946;86:668-73.
44. Susser M, Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemilogy. Am J Public Health 1996;86:674-77.
45. Planck M. Scientific autobiography and other papers. New York: Greenwood Press, 1949.
46. Pearce N, Merletti F. Complexity, simplicity, and epidemiology. Int J Epidemiol 2006;35:515-19.
47. Rothman KJ, Greenland S. edn. Modern epidemiology. 2nd edn., Philadelphia: Lippincott-Raven, 1998.
48. Saracci R. Everything should be made as simple as possible but not simpler. Int J Epidemiol 2006;35:513-14.
49. Last JM. Guidelines on ethics for epidemiologists. Int J Epidemiol 1990;19:226-29.
50. Neutra RR, Cohen A, Fletcher T et al. Toward guidelines for the ethical reanalysis and reinterpretation of another's research. Epidemiology 2006;17:335-38.
51. Prineas RJ, Goodman K, Soskolne CL et al. Findings from the American College a Epidemiology's survey on ethics, guidelines. Ann Epidemiol 1998;8:482-89.
52. Soskolne CL, Sieswerda LB: Implementing ethics in the professions: Examples from environmental epidemiology. Sci Eng Ethics 2003;9 181-90.